Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
16.23
-0.87 (-5.09%)
Sep 1, 2026, 4:00 PM EDT - Market closed
AAPG Market Cap
AAPG has a market cap or net worth of $1.51 billion as of September 2, 2026. Its market cap has decreased by -61.49% in one year.
Market Cap
1.51B
Enterprise Value
1.54B
1-Year Change
-61.49%
Ranking
Category
Stock Price
$16.23
ChartMarket Cap Chart
Since the IPO on January 24, 2025, AAPG's market cap has increased from $1.48B to $1.51B, an increase of 1.52%. That is a compound annual growth rate of 0.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 1.51B | -39.05% |
| Dec 31, 2025 | 2.47B | 66.57% |
| Jan 24, 2025 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Braveheart Bio | 1.76B |
| Syndax Pharmaceuticals | 1.74B |
| AnaptysBio | 1.67B |
| Apnimed | 1.65B |
| Bicara Therapeutics | 1.55B |
| LB Pharmaceuticals | 1.54B |
| SL Science Holding | 1.54B |
| Avalyn Pharma | 1.54B |